Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Stopped early · Phase 2

Conditions studied: Lung Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as topotecan, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: This phase II trial is studying how well high-dose topotecan works as second-line therapy in treating patients with recurrent extensive-stage small cell lung cancer.

Key facts

Study ID

NCT00087048

Run by

Case Comprehensive Cancer Center

People needed

1

Starts

2004-04-01

Expected to finish

2006-02-01

Last updated by the study team

2016-03-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Josephine Ford Cancer Center at Henry Ford Hospital — Detroit, Michigan, United States
• Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.